SkyePharma in Merck, Pfizer deals

SkyePharma (LSE:SKP) and Merck KGaA (Darmstadt, Germany) will develop a formulation of a Merck compound for use with its Geomatrix oral controlled release delivery technology. Merck will cover all of ...